Member-only story
What the Top Marijuana Experts Say About Today’s Weed
Dr. Yasmin Hurd of the Icahn School of Medicine and Dr. Jodi Gilman of Harvard School of Medicine weigh in on high potency cannabis.
A few months ago, I interviewed Mark Robinson, town manager in the state of Maine, and two leading experts in neuroscience and addictions — Dr. Yasmin Hurd of the Icahn School of Medicine and Dr. Jodi Gilman of Harvard School of Medicine. We discussed some concerns and suggestions regarding society’s newfound love affair with weed. Medicinal marijuana and recreational marijuana are both discussed, as well as the key differences between THC and CBD.
Kristen: Recreational marijuana is currently legal in eight states, and Canada is also moving in the direction of legalization. For this episode I want to look at the potential risks associated with high potency cannabis products in particular.
And to give you a background on the motivation for making this particular episode: In September 2017 I wrote an article for Genetic Literacy Project about marijuana and some of the epigenetic effects that can result from marijuana use. Marijuana enthusiasts were not pleased with me for writing my article, and they definitely let me know.
